Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent specific for Her-2-positive breast cancers
Crossref DOI link: https://doi.org/10.1007/s12282-014-0581-8
Published Online: 2015-02-19
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jiang, Qiongchao
Hao, Shaoyun
Xiao, Xiaoyun
Yao, Jiyi
Ou, Bing
Zhao, Zizhuo
Liu, Fengtao
Pan, Xin
Luo, Baoming
Zhi, Hui
License valid from 2015-02-19